Okonkwo, Rose
Tockhorn-Heidenreich, Antje
Stroud, Chad
Paget, Marie-Ange
Matharu, Manjit S.
Tassorelli, Cristina
Funding for this research was provided by:
Eli Lilly and Company
Article History
Received: 8 April 2021
Accepted: 4 September 2021
First Online: 30 September 2021
Declarations
:
: The studies were conducted in concordance with the ethical principles that have their origin in the Declaration of Helsinki guidelines. All patients provided written informed consent before study participation. The study protocols, for both the studies, were reviewed and approved by the Institutional Review Board, Medical Ethics Committee or Medical Research and Ethics Committee of the participating study sites.
: Not applicable.
: Rose Okonkwo, Antje Tockhorn-Heidenreich, Chad Stroud, and Marie-Ange Paget are employees and potential stockholders of Eli Lilly and Company and/or one of its subsidiaries. Manjit S. Matharu has received grants or contracts from Abbott and Medtronics, received consulting fees from Allergan, Eli Lilly, Novartis, and TEVA and has received payment or honoraria for lectures, presentations, speakers’ bureaus, manuscript writing or educational events from Allergan, Salvia, Eli Lilly, Novartis and TEVA. Cristina Tassorelli received grants and honoraria for advisory boards, speaker panels or investigation studies from Allergan/Abbvie, Eli-Lilly, Novartis, Teva and Medscape.